Orthopediatrics Corp (NASDAQ:KIDS) General Counsel Daniel J. Gerritzen sold 11,145 shares of the business’s stock in a transaction dated Friday, April 13th. The shares were sold at an average price of $17.92, for a total transaction of $199,718.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Orthopediatrics stock opened at $19.51 on Tuesday. The company has a market capitalization of $244.18 and a PE ratio of -3.42. Orthopediatrics Corp has a 1 year low of $14.00 and a 1 year high of $23.00. The company has a current ratio of 7.35, a quick ratio of 5.29 and a debt-to-equity ratio of 0.53.
Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Wednesday, March 7th. The company reported ($3.93) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($3.80). The firm had revenue of $11.68 million for the quarter, compared to analyst estimates of $11.45 million. research analysts forecast that Orthopediatrics Corp will post -0.66 EPS for the current year.
Several research firms have weighed in on KIDS. BTIG Research reiterated a “buy” rating and issued a $24.00 target price on shares of Orthopediatrics in a report on Friday, January 5th. BidaskClub downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Finally, Zacks Investment Research downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Two equities research analysts have rated the stock with a sell rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $23.67.
Institutional investors have recently added to or reduced their stakes in the company. Teachers Advisors LLC purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $102,000. TIAA CREF Investment Management LLC purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $130,000. California State Teachers Retirement System purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $141,000. Deutsche Bank AG purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $196,000. Finally, Tower Research Capital LLC TRC purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $217,000. 32.34% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/17/daniel-j-gerritzen-sells-11145-shares-of-orthopediatrics-corp-kids-stock.html.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.